Todd Christopher Longsworth, General Counsel at NovoCure Ltd (NVCR), sold 4,678 shares at $70.10 ($328K) on 2022-03-08, disclosed to the SEC on 2022-03-09.
Seasonal sale ($328k) by General Counsel — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.10 | 2,339 | $164K | 50.0% |
| 2 | $70.10 | 2,339 | $164K | 50.0% |
| Total | $70.10 avg | 4,678 | $328K | 100% |
| Filing → |
| NVCR | SELL | 2021-03-08 | $848K | — | Filing → |
| NVCR | SELL | 2021-03-04 | $716K | — | Filing → |
| NVCR | SELL | 2021-01-19 | $18.5M | — | Filing → |